GMABASCO
Conference update on combination cohorts
Genmab | Epcoritamab | Lymphoma
Catalyst details
Conference abstract and presentation tracking for hematology oncology pipeline.
Phase
Approved/Phase 3
Expected date
2026-06-28
Expected period
ASCO 2026
Source type
conference
exactupcoming
Source URLNotes
This record is structured for public-source tracking and manual analyst override. The database stores date confidence separately from exact dates so quarter, half-year, and estimated guidance can be handled without inventing precision.
Open company detail